Neogen (FRA:NG2) Short Interest


FRA:NG2 Neogen Corp FRA:NG2
68 GF Score
Price €7.65
GF Value €10.66
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Neogen Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:NG2 vs NVCR, ESTA, AXGN: Short Interest Comparison

For the Medical Devices subindustry, Neogen's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neogen Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neogen's Short Interest distribution charts can be found below:

* The bar in red indicates where Neogen's Short Interest falls into.


FRA:NG2
68GF Score
Neogen Corp FRA:NG2
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Neogen (FRA:NG2) Overvalued in 2026?

Based on GuruFocus' analysis, Neogen stock appears to be undervalued. The current stock price of €7.65 is trading 28.2% below its estimated GF Value™ of €10.66. GuruFocus considers Neogen to be Modestly Undervalued.

Key valuation signals for FRA:NG2:

  • Short Interest:
  • GF Value™: €10.66 vs. price of €7.65 (28.2% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the FRA:NG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neogen Business Description

Other Exchanges NEOG:USANG2:Germany
Address 620 Lesher Place, Lansing, MI, USA, 48912
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
68GF Score

Get the complete analysis for FRA:NG2

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.65
Price
€10.66
GF Value